+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global AI in Healthcare Market (2023-2028) by Sections, Diagnosis, End user and Geography. IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 175 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5451294
The Global AI in Healthcare Market is estimated to be USD 14.41 Bn in 2023 and is expected to reach USD 51.07 Bn by 2028 growing at a CAGR of 28.79%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviours of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global AI in Healthcare Market is segmented based on Sections, Diagnosis, End user and Geography.
  • By Section, the market is classified into Services, Software and Hardware
  • By Diagnosis, the market is classified into Radiology, Oncology, Neurology,
  • By End User, the market is classified into Hospitals & Healthcare Providers.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are NVIDIA Corp., Intel Corp., IBM Corp, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global AI in Healthcare Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global AI in Healthcare Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global AI in Healthcare Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the Report
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Number of Population and Chronic Diseases
4.1.2 Rising Complexities of Datasets in Healthcare Industry
4.1.3 Rising Imbalance Between Health Workforce and Patients
4.2 Restraints
4.2.1 High Cost of Systems
4.2.2 Chances of Risk of Injury and Misinterpretation due to Technical Failure
4.3 Opportunities
4.3.1 Growing Emergnece of Advanced Hardware Systems
4.3.2 Rising R&D Expenses in IT Industry
4.4 Challenges
4.4.1 Limited Acceptance of AI From Healthcare Professionals
4.4.2 Increasing Concerns Regarding Data Security
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Impact of Economic Slowdown & Impending Recession
5.6 Ansoff Matrix Analysis
6 Global AI in Healthcare Market, By Section
6.1 Introduction
6.2 Hardware
6.3 Software
6.4 Services
7 Global AI in Healthcare Market, By Diagnosis
7.1 Introduction
7.2 Radiology
7.3 Pathology
7.4 Cardiology
7.5 Oncology
7.6 Neurology
7.7 Chest and Lung
7.8 Others
8 Global AI in Healthcare Market, By End User
8.1 Introduction
8.2 Hospitals & Healthcare Providers
8.3 Patients
8.4 Pharmaceuticals & Biotechnology Companies
8.5 Healthcare Payers
8.6 Others (ACOS and MCOS)
9 Americas' AI in Healthcare Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe's AI in Healthcare Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa's AI in Healthcare Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC's AI in Healthcare Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 NVIDIA Corp.
14.2 Intel Corp.
14.3 IBM Corp.
14.4 Alphabet LLC
14.5 Microsoft Corp.
14.6 GE Healthcare
14.7 Siemens Healthineers Ag
14.8 Medtronic PLC
14.9 Micron Technologies
14.10 Amazon Web Services, Inc
14.11 Johnson&Johnson
14.12 Koninklijke Philips N.V.
14.13 General Vision Services
14.14 Cloudmex Inc.
14.15 Oncora Medical, Inc
14.16 Anju Life Sciences Software
14.17 CareSkore, Inc
14.18 Linguamatics
14.19 Enlitic, Inc.
14.20 Lunit Inc.
14.21 CureMetrix Inc.
14.22 Qure.ai Technologies Pvt. Ltd.
14.23 Context Vision Operations
14.24 Caption Health
14.25 Butterfly Network Inc.
14.26 Imagia Cybernetics Inc.
14.27 Precision Health Intelligence, LLC.
14.28 Cota Healthcare
14.29 FDNA, Inc.
14.30 Recursion Pharmaceuticals, Inc.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • NVIDIA Corp.
  • Intel Corp.
  • IBM Corp.
  • Alphabet LLC
  • Microsoft Corp.
  • GE Healthcare
  • Siemens Healthineers Ag
  • Medtronic PLC
  • Micron Technologies
  • Amazon Web Services, Inc
  • Johnson&Johnson
  • Koninklijke Philips N.V.
  • General Vision Services
  • Cloudmex Inc.
  • Oncora Medical, Inc
  • Anju Life Sciences Software
  • CareSkore, Inc
  • Linguamatics
  • Enlitic, Inc.
  • Lunit Inc.
  • CureMetrix Inc.
  • Qure.ai Technologies Pvt. Ltd.
  • Context Vision Operations
  • Caption Health
  • Butterfly Network Inc.
  • Imagia Cybernetics Inc.
  • Precision Health Intelligence, LLC.
  • Cota Healthcare
  • FDNA, Inc.
  • Recursion Pharmaceuticals, Inc."

Table Information